1. Mamalis N. Endophthalmitis. J Cataract Refract Surg. 2002; 28:729–730.
Article
2. Jabbarvand M, Hashemian H, Khodaparast M, et al. Endophthalmitis occurring after cataract surgery: outcomes of more than 480 000 cataract surgeries, epidemiologic features, and risk factors. Ophthalmology. 2016; 123:295–301.
3. Lancefield RC. A serological differentiation of human and other groups of hemolytic streptococci. J Exp Med. 1933; 57:571–595.
Article
4. Higgs TM, Neave FK, Bramley AJ. Differences in intramammary pathogenicity of four strains of Streptococcus dysgalactiae. J Med Microbiol. 1980; 13:393–399.
Article
5. Sylvetsky N, Raveh D, Schlesinger Y, et al. Bacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients. Am J Med. 2002; 112:622–626.
Article
6. Ruppen C, Rasmussen M, Casanova C, Sendi P. A 10-year observational study of Streptococcus dysgalactiae bacteraemia in adults: frequent occurrence among female intravenous drug users. Swiss Med Wkly. 2017; 147:w14469.
Article
7. Rantala S. Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection. Eur J Clin Microbiol Infect Dis. 2014; 33:1303–1310.
Article
8. Brandt CM, Spellerberg B. Human infections due to Streptococcus dysgalactiae subspecies equisimilis. Clin Infect Dis. 2009; 49:766–772.
9. Takahashi T, Ubukata K, Watanabe H. Invasive infection caused by Streptococcus dysgalactiae subsp. equisimilis: characteristics of strains and clinical features. J Infect Chemother. 2011; 17:1–10.
Article
10. Ramaswamy G, Ng A, Quinlan L, Tchertkoff V. Streptococcus equisimilis (group C) as a cause of ophthalmic infections. Am J Clin Pathol. 1983; 79:385–387.
Article
11. Wickramasinghe N, Harris K. Bilateral endophthalmitis as a primary manifestation of Streptococcus dysgalactiae endocarditis and the role of 16S rDNA polymerase chain reaction in identification. Diagn Microbiol Infect Dis. 2010; 67:185–187.
Article
12. Yong AS, Lau SY, Woo TH, et al. Streptococcus dysgalactiae endocarditis presenting as acute endophthalmitis. Infect Dis Rep. 2012; 4:e16.
Article
13. Kaliamurthy J, Cuteri V, Jesudasen N, et al. Post-operative ocular infection due to Streptococcus dysgalactiae subspecies equisimilis. J Infect Dev Ctries. 2011; 5:742–744.
Article
14. Miller JJ, Scott IU, Flynn HW Jr, et al. Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol. 2005; 139:983–987.
Article
15. Vaziri K, Schwartz SG, Kishor K, Flynn HW Jr. Endophthalmitis: state of the art. Clin Ophthalmol. 2015; 9:95–108.
16. Ravindran RD, Venkatesh R, Chang DF, et al. Incidence of post-cataract endophthalmitis at Aravind Eye Hospital: outcomes of more than 42,000 consecutive cases using standardized sterilization and prophylaxis protocols. J Cataract Refract Surg. 2009; 35:629–636.
17. Endophthalmitis Vitrectomy. Results of the Endophthalmitis Vitrectomy Study: A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995; 113:1479–1496.
18. Ciszewski M, Szewczyk EM. Potential factors enabling human body colonization by animal streptococcus dysgalactiae subsp. equisimilis Strains. Curr Microbiol. 2017; 74:650–654.
Article
19. Wolfe ND, Dunavan CP, Diamond J. Origins of major human infectious diseases. Nature. 2007; 447:279–283.
Article
20. Schrieber L, Towers R, Muscatello G, Speare R. Transmission of Streptococcus dysgalactiae subsp. equisimilis between child and dog in an Aboriginal Australian community. Zoonoses Public Health. 2014; 61:145–148.
21. Silva LG, Genteluci GL, Corrêa de, et al. Group C Streptococcus dysgalactiae subsp. equisimilis in south-east Brazil: genetic diversity, resistance profile and the first report of human and equine isolates belonging to the same multilocus sequence typing lineage. J Med Microbiol. 2015; 64(Pt 5):551–558.
Article
22. McNeilly CL, McMillan DJ. Horizontal gene transfer and recombination in Streptococcus dysgalactiae subsp. equisimilis. Front Microbiol. 2014; 5:676.
Article
23. Broyles LN, Van Beneden C, Beall B, et al. Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B. Clin Infect Dis. 2009; 48:706–712.
24. Lott MN, Fuller JJ, Hancock HA, et al. Vitreal penetration of oral moxifloxacin in humans. Retina. 2008; 28:473–476.
Article
25. Hooper CY, Lightman SL, Pacheco P, et al. Adjunctive antibiotics in the treatment of acute bacterial endophthalmitis following cataract surgery. Acta Ophthalmol. 2012; 90:e572–e573.
Article